Home › Funds › ACT Capital Partners, L.P. › SGMT
ACT Capital Partners, L.P. position in SGMT
SAGIMET BIOSCIENCES INC · Health Care
ACT Capital Partners, L.P. reported holding 60,000 shares of SGMT (SAGIMET BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$593K, representing 0.40% of its reported portfolio and ranking #29 among its reported holdings. ACT Capital Partners, L.P. first reported this position in Q3 2026.
Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR
How ACT Capital Partners, L.P.'s SGMT position evolved
ACT Capital Partners, L.P. first disclosed a stake in SGMT in Q3 2026 at 60,000 shares (US$593K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 60.00K | $592.80K | New |
About SGMT and 13F data
SGMT (SAGIMET BIOSCIENCES INC) is a Health Care company. 60 other funds we track also report a position in SGMT — the largest reported positions include SILVERARC CAPITAL MANAGEMENT, LLC (US$22.6M), BVF INC/IL (US$19.3M), Caligan Partners LP (US$19.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SGMT
- SILVERARC CAPITAL MANAGEMENT, LLC 2.93M sh · $22.63M · Q2 2026
- BVF INC/IL 2.50M sh · $19.32M · Q2 2026
- Caligan Partners LP 2.50M sh · $19.32M · Q2 2026
- Affinity Asset Advisors, LLC 2.50M sh · $19.31M · Q2 2026
- GREAT POINT PARTNERS LLC 2.03M sh · $15.69M · Q2 2026
- Saturn V Capital Management LP 1.48M sh · $11.44M · Q2 2026
- Blue Owl Capital Holdings LP 1.26M sh · $9.74M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 724.80K sh · $5.60M · Q2 2026
- Seven Fleet Capital Management LP 403.55K sh · $3.12M · Q2 2026
- Palo Alto Investors LP 250.00K sh · $1.93M · Q2 2026
- Pale Fire Capital SE 221.88K sh · $1.72M · Q2 2026
- Sofinnova Investments, Inc. 166.67K sh · $1.29M · Q2 2026
More on ACT Capital Partners, L.P.
FAQ
How long has ACT Capital Partners, L.P. held SGMT?
ACT Capital Partners, L.P. has disclosed SGMT holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ACT Capital Partners, L.P.'s current position in SGMT?
As of Q3 2026, ACT Capital Partners, L.P. holds 60.00K shares of SGMT (SAGIMET BIOSCIENCES INC), valued at $592.80K, representing 0.40% of its reported portfolio and ranking #29.
Has ACT Capital Partners, L.P. been buying or selling SGMT?
In the latest 13F filing (Q3 2026), ACT Capital Partners, L.P. newly opened its position in SGMT.
Which other funds hold SGMT?
Other major institutional holders of SGMT include SILVERARC CAPITAL MANAGEMENT, LLC, BVF INC/IL, Caligan Partners LP, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.